DTD1-AS1: A Potential Drug Target and Biomarker (G101929526)

Target Name: DTD1-AS1

NCBI ID: G101929526

Other Name(s): DTD1 antisense RNA 1

DTD1-AS1: A Potential Drug Target and Biomarker

DTD1-AS1, also known as DTD1 antisense RNA 1, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate, and its potential as a drug or biomarker has led to a growing interest in the field of biotechnology and medicine.

DTD1-AS1 is a small non-coding RNA molecule that is expressed in various tissues and organs, including the brain, heart, and liver. It is composed of four exons, which are transcribed from the DNA sequence CTAGGG in the 5' end and TGACTT in the 3' end. The exons are spliced together to form a single RNA molecule that has a length of approximately 290 nucleotides.

One of the unique features of DTD1-AS1 is its structure. It has a stem-loop structure, which is a type of RNA structure that is characterized by a repeating sequence of nucleotides that is connected to the 5' end of the molecule. The stem-loop is a common structural feature in non-coding RNAs and is thought to play a role in the stability and stability of the molecule.

Another feature of DTD1-AS1 is its expression. It is expressed in various tissues and organs, including the brain, heart, and liver, and has been shown to be involved in various physiological processes, including cell growth, apoptosis, and inflammation.

DTD1-AS1 has also been shown to play a role in the development and progression of certain diseases, including cancer. Studies have shown that high levels of DTD1-AS1 are associated with the development of certain types of cancer, such as lung cancer and liver cancer. Additionally, DTD1-AS1 has also been shown to be involved in the regulation of cellular processes that are important for cancer progression, such as cell migration and invasion.

DTD1-AS1 has also been identified as a potential biomarker for cancer. Its expression has been shown to be associated with the development and progression of certain types of cancer, and it has been shown to be a promising biomarker for cancer diagnosis and treatment.

In addition to its potential as a drug target and biomarker, DTD1-AS1 also has potential as a research tool. Its stem-loop structure and unique expression patterns make it a useful tool for studying the function and regulation of non-coding RNAs. Additionally, its expression in various tissues and organs makes it a valuable tool for studying the interconnections between different tissues and organs.

In conclusion, DTD1-AS1 is a non-coding RNA molecule that has unique structure and function. Its potential as a drug target and biomarker for various diseases has led to a growing interest in the field of biotechnology and medicine. Further research is needed to fully understand its role and potential as a research tool and therapeutic target.

Protein Name: DTD1 Antisense RNA 1

More Common Targets